|

Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve

RECRUITINGSponsored by Corcym S.r.l
Actively Recruiting
SponsorCorcym S.r.l
Started2023-11-23
Est. completion2024-12
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05898230

Summary

The objective of this study is to evaluate the medium- to long-term safety of the Carbomedics OptiForm Mitral Heart Valve after the implantation for mitral valve disease in the Chinese population. The study is designed as a post-market, retrospective, single arm and multicentric data collection

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Subject who has been treated with the Carbomedics OptiForm Mitral Heart Valve.
* Subject (or representative or family member) who can understand the objective of the study and is willing to provide verbal informed consent and the available medical information.

Exclusion Criteria:

* Subject (or legal representative or family member) who do not provide their verbal consent to the data collection, or who are unable to provide follow-up information

Conditions2

Heart DiseaseMitral Valve Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.